Related Experiment Videos
[Abnormal platelet function and ultrastructure in patients with severe viral hepatitis]
1Southwest Hospital, Third Military Medical College, Chongqing.
Zhonghua Nei Ke Za Zhi
|July 1, 1990
Summary
Severe viral hepatitis (SVH) impairs platelet function, decreasing aggregation rates and altering serotonin levels. These changes suggest in vivo platelet activation contributes to abnormal platelet function in SVH patients.
Area of Science:
- Hematology
- Hepatology
- Virology
Context:
- Severe viral hepatitis (SVH) is a critical condition affecting liver function.
- Platelets play a crucial role in hemostasis and inflammation.
- Understanding platelet behavior in SVH is essential for managing complications.
Purpose:
- To investigate the aggregation and release function of platelets.
- To examine the ultrastructure of platelets in patients with SVH.
- To correlate platelet function changes with biochemical markers.
Summary:
- Platelet aggregation rates were significantly reduced in SVH patients.
- Platelet serotonin (5-HT) levels decreased while plasma 5-hydroxyindole (5-HIs) increased.
- Ultrastructural analysis revealed platelet renewal, denaturation, and in vivo activation.
Impact:
- Abnormal platelet function and ultrastructure in SVH are linked to in vivo platelet activation.
- Findings provide insights into the pathophysiology of SVH-related hemostatic disorders.
- Highlights the need for monitoring platelet function in severe viral hepatitis management.